Total Company Value: immunovant.com (IMVT)
Immunovant, Inc. (IMVT), a subsidiary of Roivant, specializes in developing batocizumab, a universal injectable agent for treating rare autoimmune pathologies. Expectations regarding clinical trial results are already priced in, while the primary growth catalysts are linked to future regulatory approvals. This chart of exchange-traded quotes reflects an Enterprise Value of 5167.44. The high barrier to entry in the sector is driven by colossal R&D expenditures and the complexity of biotechnologies.
Immunovant, Inc. (IMVT) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Immunovant Inc (IMVT)
Enterprise value reflects the total acquisition cost of a business, summing market capitalization and net debt to determine the actual cost for an acquirer. By analyzing the adjusted enterprise value, an investor can see how the financial burden impacts the valuation of Immunovant, Inc. (IMVT), whose value is based on the commercialization potential of innovative targeted therapies for autoimmune diseases.
Competitor analysis for Immunovant, Inc.
ARGX - Real Price to Acquire Entire Company|BNTX - Real Price to Acquire Entire Company|Abivax Pharma (ABVX) - Total Company Value|ADMA - Real Price to Acquire Entire Company|PTGX (protagonist-inc.com) - Aggregate Business Value|Total Company Value Kiniksa KNSA|Full Business Value Grifols SA|Adaptive Biotechnologies Corp (ADPT) - Enterprise Value|Value Adjusted for Debt and Cash Celldex Corp (CLDX)|Enterprise Value AUPH (Aurinia Pharmaceuticals)|biocryst.com - Enterprise Value|Total Company Value Vera Therapeutics (VERA)|DNTH: Value Adjusted for Debt and Cash|PHVS (Pharvaris Corp) - Total Company Value|AbCellera Biologics Inc. (ABCL) - Real Price to Acquire Entire Company|TRML (Tourmaline Bio, Inc.) - Enterprise Value|Enterprise Value precigen.com (PGEN)|Pharming Group (PHAR) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Nektar Therapeutics Inc (NKTR)|Enterprise Value UPB|Zenas Corp - Company Buyout Price|IMNM: Total Company Value|GOSS: Real Price to Acquire Entire Company|KALV (KalVista Pharmaceuticals, Inc.) - Total Company Value|Real Price to Acquire Entire Company Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Real Price to Acquire Entire Company|Enterprise Value SVRA|Total Company Value Rigel Pharmaceuticals RIGL|Business Value anaptysbio.com (ANAB)|ATXS: Enterprise Value|Total Enterprise Value enGene Holdings Inc ENGN|Enterprise Value RAPT (RAPT Therapeutics)|JBIO: Company Buyout Price|ACRS (Aclaris Therapeutics) - Total Company Value|KYTX (kyvernatx.com) - Real Price to Acquire Entire Company|Total Company Value TLSA|Real Price to Acquire Entire Company Cabaletta Bio Inc. (CABA)|Real Price to Acquire Entire Company VTYX|Enterprise Value THTX (Theratechnologies, Inc)|AVTX - Total Company Value|eledon.com - Business Value|AGEN (Agenus Inc.) - Total Company Value|Climb Bio Inc. (CLYM) - Total Enterprise Value|Zura Bio (ZURA) - Real Price to Acquire Entire Company|aTyr Pharmaceuticals (ATYR) - Total Company Value|ADAG (Adagene Inc) - Enterprise Value|Enterprise Value IMA|Total Company Value Shattuck Labs, Inc. STTK|Business Value equilliumbio.com EQ|Real Price to Acquire Entire Company Connect Biopharma Holdings Limited (CNTB)|IMUX - Aggregate Business Value|Real Price to Acquire Entire Company Atara Biotherapeutics Inc (ATRA)|IFRX - Value Adjusted for Debt and Cash|X4 Pharmaceuticals, Inc. - Enterprise Value|ACET (Adicet Bio, Inc.) - Company Buyout Price|Total Company Value Celularity Inc (CELU)|Business Value INmune Bio Corporation|Enterprise Value BRNS (Barinthus Biotherapeutics)|Real Price to Acquire Entire Company kezarlifesciences.com KZR|Real Price to Acquire Entire Company SABS|Company Buyout Price Akari Therapeutics PLC AKTX|Enterprise Value ENLV (Enlivex Therapeutics, Ltd.)|QTTB: Company Buyout Price|GOVX (GeoVax Labs, Inc.) - Total Company Value|Real Price to Acquire Entire Company edesabiotech.com|Real Price to Acquire Entire Company iBio|Total Company Value Carisma Tx (CARM)|Real Price to Acquire Entire Company XTL Biopharmaceuticals, Ltd.|Aggregate Business Value BOLT (boltbio.com)|HCW Biologics (HCWB) - Total Company Value|Full Business Value Aptevo Therapeutics, Inc. APVO|Enterprise Value AIM ImmunoTech Inc. (AIM)|ADTX - Value Adjusted for Debt and Cash|GRI: Enterprise Value|XRTX (XORTX Corp) - Enterprise Value|HIND - Total Company Value|Value Adjusted for Debt and Cash REVB|Total Company Value INDP (Indaptus Therapeutics, Inc.)|Real Price to Acquire Entire Company Scinai Immunotherapeutics Ltd (SCNI)|Enterprise Value CALI (CalciMedica)|AFMD - Enterprise Value|Real Price to Acquire Entire Company Allakos Therapeutics (ALLK)|HOOK - Value Adjusted for Debt and Cash|igmbio.com - Enterprise Value|ITOS (iTeos Therapeutics Inc) - Company Buyout Price|Total Company Value OCEA|Real Price to Acquire Entire Company TCBP|Total Company Value THRD (Third Harmonic Bio)